A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

Show other versions (1)

Aims/hypothesis: An accurate molecular diagnosis of diabetes subtype confers clinical benefits; however, many individuals with monogenic diabetes remain undiagnosed. Biomarkers could help to prioritise patients for genetic investigation. We recently demonstrated that high-sensitivity C-reactive prot...

Full description

Bibliographic Details
Main Authors: Thanabalasingham, G, Shah, N, Vaxillaire, M, Hansen, T, Tuomi, T, Gašperíková, D, Szopa, M, Tjora, E, James, T, Kokko, P, Loiseleur, F, Andersson, E, Gaget, S, Isomaa, B, Nowak, N, Raeder, H, Stanik, J, Njolstad, P, Malecki, M, Klimes, I, Groop, L, Pedersen, O, Froguel, P, McCarthy, M, Gloyn, A
Format: Journal article
Language:English
Published: 2011

Similar Items